Avanos Medical (AVNS) Income from Discontinued Operations (2017)
Avanos Medical (AVNS) reported Income from Discontinued Operations of 12400000.0 for Q3 2017.
Avanos Medical (AVNS) Income from Discontinued Operations (2017) Analysis & Trends
Avanos Medical (AVNS) has 1 years of Income from Discontinued Operations data on file, last reported at 12400000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn | - |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 12.40 Mn |